Theravance Biopharma Inc’s recent filing unveils that its 10% Owner Samaha Eli acquired Company’s shares for reported $13.12 million on May 01 ’24. In the deal valued at $8.75 per share,1,499,124 shares were bought. As a result of this transaction, Samaha Eli now holds 8,511,350 shares worth roughly $81.71 million.
Then, Farnum Rhonda sold 1,254 shares, generating $10,922 in total proceeds. Upon selling the shares at $8.71, the SVP, COMM & MEDICAL AFFAIRS now owns 311,733 shares.
Before that, Farnum Rhonda sold 1,378 shares. Theravance Biopharma Inc shares valued at $14,180 were divested by the SVP, COMM & MEDICAL AFFAIRS at a price of $10.29 per share. As a result of the transaction, Farnum Rhonda now holds 331,206 shares, worth roughly $3.18 million.
BTIG Research initiated its Theravance Biopharma Inc [TBPH] rating to a Buy in a research note published on April 12, 2024; the price target was $21. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who decreased its forecast for the stock in early January from “an Outperform” to “an In-line”. SVB Leerink began covering TBPH with “an Outperform” recommendation on May 23, 2022. JP Morgan revised its rating on November 05, 2021. It rated TBPH as “a Neutral” which previously was an “an Underweight”.
Price Performance Review of TBPH
On Monday, Theravance Biopharma Inc [NASDAQ:TBPH] saw its stock jump 1.48% to $9.60. Over the last five days, the stock has gained 6.79%. Theravance Biopharma Inc shares have fallen nearly -14.59% since the year began. Nevertheless, the stocks have fallen -14.59% over the past one year. While a 52-week high of $11.98 was reached on 01/04/24, a 52-week low of $8.21 was recorded on 02/08/24. SMA at 50 days reached $9.11, while 200 days put it at $9.60. A total of 0.54 million shares were traded, compared to the trading of 0.46 million shares in the previous session.
Levels Of Support And Resistance For TBPH Stock
The 24-hour chart illustrates a support level at 9.33, which if violated will result in even more drops to 9.06. On the upside, there is a resistance level at 10.12. A further resistance level may holdings at 10.64. The Relative Strength Index (RSI) on the 14-day chart is 57.04, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.27, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 39.09%. Stochastics %K at 64.64% indicates the stock is a holding.
